Napierska Dorota, Thomassen Leen C J, Rabolli Virginie, Lison Dominique, Gonzalez Laetitia, Kirsch-Volders Micheline, Martens Johan A, Hoet Peter H
Laboratory of Lung Toxicology, Katholieke Universiteit Leuven, Herestraat 49, 3000 Leuven, Belgium.
Small. 2009 Apr;5(7):846-53. doi: 10.1002/smll.200800461.
The effect that monodisperse amorphous spherical silica particles of different sizes have on the viability of endothelial cells (EAHY926 cell line) is investigated. The results indicate that exposure to silica nanoparticles causes cytotoxic damage (as indicated by lactate dehydrogenase (LDH) release) and a decrease in cell survival (as determined by the tetrazolium reduction, MTT, assay) in the EAHY926 cell line in a dose-related manner. Concentrations leading to a 50% reduction in cell viability (TC(50)) for the smallest particles tested (14-, 15-, and 16-nm diameter) ranging from 33 to 47 microg cm(-2) of cell culture differ significantly from values assessed for the bigger nanoparticles: 89 and 254 microg cm(-2) (diameter of 19 and 60 nm, respectively). Two fine silica particles with diameters of 104 and 335 nm show very low cytotoxic response compared to nanometer-sized particles with TC(50) values of 1095 and 1087 microg cm(-2), respectively. The smaller particles also appear to affect the exposed cells faster with cell death (by necrosis) being observed within just a few hours. The surface area of the tested particles is an important parameter in determining the toxicity of monodisperse amorphous silica nanoparticles.
研究了不同尺寸的单分散无定形球形二氧化硅颗粒对内皮细胞(EAHY926细胞系)活力的影响。结果表明,暴露于二氧化硅纳米颗粒会导致EAHY926细胞系出现细胞毒性损伤(以乳酸脱氢酶(LDH)释放表示)以及细胞存活率下降(通过四唑盐还原法即MTT法测定),且呈剂量相关关系。对于测试的最小颗粒(直径为14、15和16纳米),导致细胞活力降低50%(TC(50))的浓度范围为33至47微克/平方厘米细胞培养物,这与较大纳米颗粒评估的值(分别为直径19和60纳米的颗粒,其值为89和254微克/平方厘米)有显著差异。与纳米尺寸颗粒相比,直径为104和335纳米的两种细二氧化硅颗粒显示出非常低的细胞毒性反应,其TC(50)值分别为1095和1087微克/平方厘米。较小的颗粒似乎也能更快地影响暴露的细胞,仅在几小时内就观察到细胞死亡(通过坏死)。测试颗粒的表面积是决定单分散无定形二氧化硅纳米颗粒毒性的一个重要参数。
Toxicol Appl Pharmacol. 2006-12-15
Toxicol Appl Pharmacol. 2009-10-1
Toxicol In Vitro. 2011-5-7
Drug Deliv Transl Res. 2025-6-14
Int J Mol Sci. 2024-10-9